SWOG clinical trial number
SWOG-7303

Chemotherapy of Disseminated Testicular Carcinoma with Vinblastine (NSC-49842) and Bleomycin (NSC- 125066) or Actinomycin-D (NSC-3053), Bleomycin and Vincristine (NSC-67574)

Closed
Phase
III
Abbreviated Title
Chemotherapy of Disseminated Testicular Carcinoma with Vinblastine (NSC-49842) and Bleomycin (NSC- 125066) or Actinomycin-D (NSC-3053), Bleomycin and Vincristine (NSC-67574)
Activated
02/21/1973
Closed
06/12/1975

Research committees

Genitourinary Cancer

Publication Information Expand/Collapse

1978

Chemotherapy of disseminated germinal tumors of the testis - comparison of vinblastine and bleomycin with vincristine, bleomycin and actinomycin D.

SC Spigel;RL Stephens;CD Haas;SE Jones;D Lehane;TE Moon;CA Coltman Jr Cancer Treat Rep 62(1):129-130

1974

Combination chemotherapy of testicular carcinoma.

SC Spigel;CA Coltman Jr ASCO

1973

Combination chemotherapy of testicular carcinoma.

SC Spigel;CA Coltman Jr ASCO

Other Clinical Trials

SWOG Clinical Trial Number
S1806

Phase III Randomized Trial of Concurrent Chemoradiotherapy with or Without Atezolizumab in Localized Muscle Invasive Bladder Cancer.

Research Committee(s)
Genitourinary Cancer
Activated
04/19/2019
Accrual
2%
Open
Phase
III
SWOG Clinical Trial Number
S1802
SWOG Clinical Trial Number
CTSU/EA8153